ERBB3 and prostate cancer: Previous studies demonstrated that NRG (ErbB3 and ErbB4 ligand) inhibits growth of the androgen dependent LNCaP prostate cancer cells when cultured in complete medium [28] while in the absence of androgen, NRG induced death of LNCaP cells [29].